Theratechnologies Inc. (TH.TO)
CAD 3.97
(1.53%)
CAD 3.97
(1.53%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.91 USD | -82.0% |
| 2022 | -0.50 USD | -47.06% |
| 2021 | -0.34 USD | -17.24% |
| 2020 | -0.29 USD | -26.09% |
| 2019 | -0.23 USD | -285.91% |
| 2018 | -0.06 USD | 70.2% |
| 2017 | -0.20 USD | -2802.7% |
| 2016 | 0.01 USD | -66.96% |
| 2015 | 0.02 USD | 114.93% |
| 2014 | -0.15 USD | -139.62% |
| 2013 | -0.06 USD | 72.78% |
| 2012 | -0.23 USD | 17.86% |
| 2011 | -0.28 USD | -286.67% |
| 2010 | 0.15 USD | 162.5% |
| 2009 | -0.24 USD | 65.22% |
| 2008 | -0.69 USD | 2.82% |
| 2007 | -0.71 USD | -33.96% |
| 2006 | -0.53 USD | -55.88% |
| 2005 | -0.34 USD | 39.29% |
| 2004 | -0.56 USD | 31.71% |
| 2003 | -0.82 USD | -173.33% |
| 2002 | -0.30 USD | -148.39% |
| 2001 | 0.62 USD | 287.5% |
| 2000 | 0.16 USD | 200.0% |
| 1999 | -0.16 USD | 11.11% |
| 1998 | -0.18 USD | 25.0% |
| 1997 | -0.24 USD | 0.0% |
| 1996 | -0.24 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.02 USD | 122.03% |
| 2024 Q1 | -0.09 USD | -7.84% |
| 2024 Q3 | 0.06 USD | 200.0% |
| 2023 FY | - USD | -82.0% |
| 2023 Q4 | -0.08 USD | -173.38% |
| 2023 Q2 | -0.10 USD | 9.09% |
| 2023 Q1 | -0.11 USD | -32.05% |
| 2023 Q3 | -0.03 USD | 69.2% |
| 2022 Q4 | -0.08 USD | -4.91% |
| 2022 Q3 | -0.08 USD | 66.92% |
| 2022 Q2 | -0.24 USD | -152.63% |
| 2022 FY | - USD | -47.06% |
| 2022 Q1 | -0.10 USD | 5.0% |
| 2021 Q3 | -0.10 USD | -47.93% |
| 2021 FY | - USD | -17.24% |
| 2021 Q4 | -0.10 USD | 0.0% |
| 2021 Q1 | -0.07 USD | -6.72% |
| 2021 Q2 | -0.07 USD | 3.29% |
| 2020 Q2 | -0.08 USD | -27.8% |
| 2020 Q1 | -0.06 USD | 29.68% |
| 2020 FY | - USD | -26.09% |
| 2020 Q4 | -0.07 USD | 25.48% |
| 2020 Q3 | -0.09 USD | -16.58% |
| 2019 Q4 | -0.08 USD | -293.9% |
| 2019 Q2 | -0.04 USD | -158.13% |
| 2019 Q1 | -0.02 USD | -37.93% |
| 2019 FY | - USD | -285.91% |
| 2019 Q3 | -0.02 USD | 48.43% |
| 2018 Q4 | -0.01 USD | -413.51% |
| 2018 FY | - USD | 70.2% |
| 2018 Q1 | -0.03 USD | 32.84% |
| 2018 Q2 | -0.03 USD | 7.66% |
| 2018 Q3 | 0.00 USD | 114.62% |
| 2017 Q1 | -0.02 USD | -1505.88% |
| 2017 FY | - USD | -2802.7% |
| 2017 Q4 | -0.04 USD | -32.9% |
| 2017 Q3 | -0.03 USD | 66.74% |
| 2017 Q2 | -0.09 USD | -286.19% |
| 2016 FY | - USD | -66.96% |
| 2016 Q1 | -0.00 USD | -131.48% |
| 2016 Q2 | -0.01 USD | -241.18% |
| 2016 Q3 | 0.01 USD | 231.03% |
| 2016 Q4 | 0.00 USD | -77.63% |
| 2015 Q2 | 0.01 CAD | 166.67% |
| 2015 Q1 | -0.01 USD | 74.19% |
| 2015 Q4 | 0.01 USD | -64.24% |
| 2015 FY | - USD | 114.93% |
| 2015 Q3 | 0.02 USD | 88.75% |
| 2014 FY | - USD | -139.62% |
| 2014 Q4 | -0.05 USD | 29.76% |
| 2014 Q3 | -0.07 USD | -459.78% |
| 2014 Q2 | 0.02 USD | 135.32% |
| 2014 Q1 | -0.05 USD | -30.58% |
| 2013 FY | - USD | 72.78% |
| 2013 Q2 | -0.02 USD | -175.09% |
| 2013 Q4 | -0.04 USD | -32.56% |
| 2013 Q1 | 0.03 USD | 140.92% |
| 2013 Q3 | -0.03 USD | -36.82% |
| 2012 Q4 | -0.07 USD | -522.61% |
| 2012 FY | - USD | 17.86% |
| 2012 Q3 | -0.01 USD | 48.89% |
| 2012 Q2 | -0.02 USD | 81.25% |
| 2012 Q1 | -0.12 USD | -837.5% |
| 2011 Q3 | -0.07 USD | 30.0% |
| 2011 Q2 | -0.10 USD | 0.0% |
| 2011 Q1 | -0.10 USD | -129.41% |
| 2011 FY | - USD | -286.67% |
| 2011 Q4 | -0.01 USD | 81.71% |
| 2010 Q4 | 0.34 USD | 765.36% |
| 2010 Q3 | -0.05 USD | 31.68% |
| 2010 Q2 | -0.07 USD | -11.31% |
| 2010 Q1 | -0.07 USD | 14.94% |
| 2010 FY | - USD | 162.5% |
| 2009 Q3 | 0.09 USD | 210.67% |
| 2009 Q2 | -0.08 USD | 41.07% |
| 2009 FY | - USD | 65.22% |
| 2009 Q4 | -0.08 USD | -186.53% |
| 2009 Q1 | -0.14 USD | -7.69% |
| 2008 Q4 | -0.13 CAD | 27.78% |
| 2008 Q2 | -0.20 CAD | 0.0% |
| 2008 Q1 | -0.20 CAD | 4.76% |
| 2008 FY | - USD | 2.82% |
| 2008 Q3 | -0.18 CAD | 10.0% |
| 2007 Q4 | -0.21 CAD | -23.53% |
| 2007 Q2 | -0.14 CAD | 17.65% |
| 2007 FY | - USD | -33.96% |
| 2007 Q1 | -0.17 CAD | -41.67% |
| 2007 Q3 | -0.17 CAD | -21.43% |
| 2006 Q3 | -0.14 CAD | -7.69% |
| 2006 FY | - USD | -55.88% |
| 2006 Q1 | -0.13 CAD | 7.14% |
| 2006 Q2 | -0.13 CAD | 0.0% |
| 2006 Q4 | -0.12 CAD | 14.29% |
| 2005 FY | - USD | 39.29% |
| 2005 Q4 | -0.14 CAD | -16.67% |
| 2005 Q3 | -0.12 USD | 58.62% |
| 2005 Q2 | -0.29 CAD | -238.1% |
| 2005 Q1 | 0.21 CAD | 175.0% |
| 2004 FY | - USD | 31.71% |
| 2004 Q4 | -0.28 CAD | -214.25% |
| 2004 Q3 | -0.09 USD | 25.75% |
| 2004 Q1 | -0.04 CAD | 87.86% |
| 2004 Q2 | -0.12 CAD | -167.26% |
| 2003 FY | - USD | -173.33% |
| 2003 Q4 | -0.37 CAD | -146.67% |
| 2003 Q3 | -0.15 CAD | 6.25% |
| 2003 Q2 | -0.16 CAD | -33.33% |
| 2003 Q1 | -0.12 CAD | 25.0% |
| 2002 Q1 | -0.03 CAD | 71.92% |
| 2002 Q3 | -0.10 CAD | -7042.86% |
| 2002 Q4 | -0.16 CAD | -60.0% |
| 2002 FY | - USD | -148.39% |
| 2002 Q2 | -0.00 CAD | 95.85% |
| 2001 FY | - USD | 287.5% |
| 2001 Q4 | -0.12 CAD | -116.22% |
| 2001 Q3 | 0.74 CAD | 1038.46% |
| 2001 Q2 | 0.06 CAD | 216.28% |
| 2001 Q1 | -0.06 CAD | -155.9% |
| 2000 FY | - USD | 200.0% |
| 2000 Q1 | -0.05 CAD | -4.78% |
| 2000 Q2 | -0.06 USD | -24.69% |
| 2000 Q3 | 0.14 USD | 332.95% |
| 2000 Q4 | 0.10 CAD | -28.57% |
| 1999 Q4 | -0.05 USD | -14.71% |
| 1999 Q2 | -0.04 USD | -2.26% |
| 1999 Q1 | -0.04 USD | -0.51% |
| 1999 FY | - USD | 11.11% |
| 1999 Q3 | -0.04 USD | 1.47% |
| 1998 FY | - USD | 25.0% |
| 1998 Q4 | -0.04 USD | 10.61% |
| 1998 Q1 | -0.06 USD | -28.31% |
| 1998 Q3 | -0.04 USD | 19.31% |
| 1998 Q2 | -0.05 USD | 2.31% |
| 1997 Q1 | -0.06 USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q2 | -0.07 USD | -24.1% |
| 1997 Q3 | -0.06 USD | 20.66% |
| 1997 Q4 | -0.04 USD | 23.96% |
| 1996 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aurora Cannabis Inc. | -1.60 CAD | 43.125% |
| Avicanna Inc. | -0.09 CAD | -877.444% |
| Avant Brands Inc. | -0.61 CAD | -49.18% |
| Cardiol Therapeutics Inc. | -0.44 CAD | -106.818% |
| Crescita Therapeutics Inc. | -0.10 CAD | -828.571% |
| Knight Therapeutics Inc. | -0.16 CAD | -468.75% |
| MediPharm Labs Corp. | -0.04 CAD | -2427.778% |
| OrganiGram Holdings Inc. | -2.82 CAD | 67.73% |
| Canopy Growth Corporation | -8.79 CAD | 89.647% |
| Willow Biosciences Inc. | -0.10 CAD | -810.0% |
| Auxly Cannabis Group Inc. | -0.04 CAD | -1926.726% |